Covalon Technologies Ltd. COV

TVX: COV | ISIN: CA22282D3022   31/05/2024
2,180 CAD (+4,31%)
(+4,31%)   31/05/2024

26 april 2023 · Compassionate Care Solutions Provider Covalon Participating in the Canadian Vascular Access Association and World Congress on Vascular Access Joint Conference on April 26-28, 2023 in Toronto · Persbericht

27 maart 2023 · Covalon Presents New CLABSI Conscious Series Webinar: Protecting CVADs from Gross Contamination · Persbericht

20 maart 2023 · Leader in Compassionate Care Infection Prevention Solutions, Covalon, to Participate in the Synova NICU Leadership Forum 2023 in Tucson, Arizona from March 19 to 23, 2023 · Persbericht

9 maart 2023 · Covalon Announces Voting Results from Fiscal 2022 Annual and Special Meeting of Shareholders · Persbericht

9 maart 2023 · Covalon Welcomes Martin Goldfarb, O.C., to its Board of Directors · Persbericht

28 februari 2023 · Covalon To Hold Annual and Special Meeting of Shareholders on Wednesday, March 8, 2023 · Persbericht

23 februari 2023 · Covalon Announces Improved First Quarter Fiscal 2023 Results · Persbericht

20 februari 2023 · Infection Prevention Solutions Provider Covalon to Participate for the First Time in NEO - The Conference for Neonatology in Las Vegas, NV on February 22-24, 2023 · Persbericht

18 februari 2023 · Covalon Announces Conference Call to Discuss First Quarter Fiscal 2023 Financial Results · Persbericht

26 januari 2023 · Covalon Announces Fourth Quarter and Year End Results for Fiscal 2022 and Highlights Company Transformation Changes · Persbericht

23 januari 2023 · Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2022 Financial Results · Persbericht

21 november 2022 · Covalon's SurgiClear Dressing Plays an Important Part in Preventing Surgical Wound Infections at Top Children's Hospital · Persbericht

8 november 2022 · Covalon Launches New "CLABSI Conscious" Campaign to Help Children Heal Without Infections · Persbericht

1 november 2022 · Closing Chronic Wounds with Collagen Powder: University of Michigan case study demonstrates the efficacy of ColActive Plus Powder in resolving non-healing wounds · Persbericht

11 oktober 2022 · Covalon to Participate in the American Nurses Credentialing Center Magnet Conference in Philadelphia · Persbericht

28 september 2022 · Covalon to Participate in the 12th International Pediatric Intestinal Failure and Rehabilitation Symposium in Toronto · Persbericht

26 september 2022 · Covalon to Showcase Infection Prevention Solutions at the Association for Vascular Access Annual Scientific Meeting · Persbericht

20 september 2022 · Covalon's Dual Antimicrobial Surgical Site Dressing Adopted by Leading US Pediatric Hospital's Congenital Heart Program · Persbericht

13 september 2022 · Covalon to Introduce New Infection Prevention Products at the Annual Association of Pediatric Hematology/Oncology Nurses (APHON) Conference · Persbericht

8 september 2022 · Covalon Announces Expansion of its United States Pediatric Hospital Customer Base · Persbericht

Mijn selecties